[Quick Survey] SingHealth-UCL Global Pharmacy Connect Initiative

2 views
Skip to first unread message

Renzo Guinto

unread,
Mar 1, 2026, 5:01:56 PMMar 1
to
Dear colleagues,

I hope this email finds you in good health!
I am writing to invite you to complete a short (5–7 minute) survey as part of the Global Pharmacy Connect initiative, delivered in collaboration between SingHealth and the UCL School of Pharmacy.
The survey seeks perspectives from pharmacy and medical leaders, regulators, educators and industry partners on:
  • substandard and falsified medical products
  • the use of digital technologies in pharmacy practice and education
  • global pharmacy advocacy across multi-disciplinary levels 
The findings will inform the development of the Global Pharmacy Connect Roadmap, which aims to identify current priorities and gaps in pharmacy education, practice and advocacy aligned with the above themes.
Grateful if you can kindly share this with your networks - especially those who work in pharmacy and on medical products.
We are also hosting a series of virtual discussions and workshops from 4–6 March 2026. These are scheduled in Singapore time and may be convenient for colleagues based in other regions or travelling internationally. Please register using the link here, or as provided in the attached poster.
Thank you for your time and consideration. 
Best regards,
Renzo 

signature_1782090942

A/Prof Renzo R. GUINTO, MD DrPH


Associate Professor of Global and Planetary Health

Lead, Planetary Health Programme

SingHealth Duke-NUS Global Health Institute

Duke-NUS Medical School | 8 College Road, Singapore 169857 

https://www.duke-nus.edu.sg/directory/detail/renzo-guinto 

 

ImageImageImage


Important: This email is confidential and may be privileged. If you are not the intended recipient, please delete it and notify us immediately; you should not copy or use it for any purpose nor disclose its contents to any other person. Thank you.  

Global Pharmacy Connect Regional Stakeholder Engagement.pdf
Reply all
Reply to author
Forward
0 new messages